Last reviewed · How we verify
Alevaire (TYLOXAPOL)
At a glance
| Generic name | TYLOXAPOL |
|---|---|
| Sponsor | GSK |
| Drug class | tyloxapol |
| Therapeutic area | Respiratory |
| Phase | FDA-approved |
| First approval | 1990 |
Approved indications
- Respiratory distress syndrome in the newborn
Common side effects
Key clinical trials
- Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection
- Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome (PHASE2,PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |